Methods, materials and apparatus for treating bone and other tissue
US-9504508-B2 · Nov 29, 2016 · US
US9642932B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9642932-B2 |
| Application number | US-37789407-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 11, 2007 |
| Priority date | Sep 14, 2006 |
| Publication date | May 9, 2017 |
| Grant date | May 9, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A bone cement comprising an acrylic polymer mixture which is formulated to have a relatively high viscosity for a relatively long window, due to distributions of molecular weights and/or sizes of acrylic beads.
Opening claim text (preview).
The invention claimed is: 1. A cement kit, comprising: (a) a liquid component including a monomer; and (b) a powder component including polymeric beads, in which the distribution of the molecular weight of the powder component is non-normal so that it is skewed to a higher molecular weight by introduction of higher molecular weight beads, the non-normal distribution of the molecular weight of the powder component causing (a) an increase in the immediate viscosity of a mixture of the liquid and powder components and compared with a cement having a substantially normal distribution, and (b) an increase in the length of the working window period in which the viscosity of the cement does not exceed 500 Pa.s compared with a cement having a substantially normal distribution. 2. A cement kit according to claim 1 , in which the higher molecular weight beads have an average molecular weight of at least a factor of 2 of an average molecular weight of the polymeric beads. 3. A cement kit according to claim 2 , in which the factor is at least 3. 4. A cement kit according to claim 3 , in which the factor is at least 5. 5. A cement kit according to claim 1 , further comprising a relatively small component including smaller sized beads. 6. A cement kit according to claim 1 , wherein the polymeric beads comprise PMMA. 7. A cement kit according to claim 1 , wherein the higher molecular weight beads have a molecular weight of about 600,000 Dalton to about 5,000,000 Dalton. 8. A cement kit according to claim 1 , wherein the higher molecular weight beads have a molecular weight of about 3,000,000 to 4,000,000 Dalton. 9. A cement kit according to claim 1 , wherein the higher molecular weight beads have a molecular weight of about 3,500,000 to 3,900,000 Dalton. 10. A cement kit according to claim 1 , wherein an average molecular weight of the polymeric beads is about 130,000 to 170,000 Dalton. 11. A cement kit according to claim 1 , wherein an average molecular weight of the polymeric beads is about 375,000 Dalton.
Compositions characterised by their physical properties · CPC title
obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)} · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence) · CPC title
Flowable or injectable implant compositions · CPC title
containing inorganic materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.